Phase 4Completed
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
- Sponsor
- Wake Forest University Health Sciences (Academic or other)
- Enrolment
- 22 enrolled
- Conditions
- Lipid Disorder
- Interventions
- moderate- or high-intensity statin/ rosuvastatin
- Ages
- adults, older adults
- Registry
- NCT05742841
From the registry
The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3) prescribing a moderate- or high-intensity statin if applicable, and 4) referring patients to outpatient care (primary care, preventive cardiology, or general cardiology, depending on risk level).
Primary outcomes
- Low-density Lipoprotein Cholesterol (LDL-C) Levels at Baseline and Day 30